GB1093293A - New pharmaceutical composition - Google Patents

New pharmaceutical composition

Info

Publication number
GB1093293A
GB1093293A GB26220/66A GB2622066A GB1093293A GB 1093293 A GB1093293 A GB 1093293A GB 26220/66 A GB26220/66 A GB 26220/66A GB 2622066 A GB2622066 A GB 2622066A GB 1093293 A GB1093293 A GB 1093293A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
vitamin
new pharmaceutical
adenine
batyl alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB26220/66A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ILE DE RECH S PHARMA EN ABREGE
Original Assignee
ILE DE RECH S PHARMA EN ABREGE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ILE DE RECH S PHARMA EN ABREGE filed Critical ILE DE RECH S PHARMA EN ABREGE
Publication of GB1093293A publication Critical patent/GB1093293A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB26220/66A 1965-06-23 1966-06-13 New pharmaceutical composition Expired GB1093293A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR28021980 1965-06-23
FR28036560 1965-10-28

Publications (1)

Publication Number Publication Date
GB1093293A true GB1093293A (en) 1967-11-29

Family

ID=26235364

Family Applications (1)

Application Number Title Priority Date Filing Date
GB26220/66A Expired GB1093293A (en) 1965-06-23 1966-06-13 New pharmaceutical composition

Country Status (3)

Country Link
BE (1) BE680858A (enExample)
FR (1) FR4696M (enExample)
GB (1) GB1093293A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2140689A (en) * 1983-05-30 1984-12-05 Mitsui Toatsu Chemicals Treating digestive ulcers using dna
US20160250243A1 (en) * 2013-10-21 2016-09-01 Lunan Pharmaceutical Group Corporation Use of icaritin in preparing medicament for preventing or treating hematocytopenia

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2140689A (en) * 1983-05-30 1984-12-05 Mitsui Toatsu Chemicals Treating digestive ulcers using dna
US20160250243A1 (en) * 2013-10-21 2016-09-01 Lunan Pharmaceutical Group Corporation Use of icaritin in preparing medicament for preventing or treating hematocytopenia
US10555962B2 (en) * 2013-10-21 2020-02-11 Lunan Pharmaceutical Group Corporation Use of icaritin in preparing medicament for preventing or treating hematocytopenia
US10799521B2 (en) 2013-10-21 2020-10-13 Lunan Pharmaceutical Group Corporation Use of icaritin in preparing medicament for preventing or treating hematocytopenia

Also Published As

Publication number Publication date
FR4696M (enExample) 1966-12-26
BE680858A (enExample) 1966-11-14

Similar Documents

Publication Publication Date Title
IT1164550B (it) Prodotto medicinale da somministrare per via orale dotato di azione antiflogistica
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
SE8402551L (sv) Cinnamoylmoranolin-derivat
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
IT8322630A0 (it) Preparato di medicamento per migliorare i sintomi del cancro.
EP0012639A3 (en) Quinolein-3-carboxylic acid derivatives, process for their preparation, their use in medicines and pharmaceutical compositions containing them
NL150096B (nl) Werkwijze voor het bereiden van gesubstitueerde (alpha)-fenoxycarbonzuurderivaten met cholesterol- of lipidegehalte verlagende werking, werkwijze voor het bereiden van een therapeutisch preparaat en gevormd therapeutisch preparaat.
KR890006227A (ko) 페놀-함유 진해성 액체 조성물
ATE6357T1 (de) Substituierte acetophenone, deren herstellung und pharmazeutische praeparate, die sie enthalten.
SE8501312L (sv) Oral doseringsform for etopsid
GB1065910A (en) Purified extracts of gleditsia species and compositions thereof
GB1013578A (en) Analgesic composition
ATE82128T1 (de) Pharmazeutische zusammensetzungen zur behandlung von krebs.
GB1110086A (en) Improvements in pharmaceutical anti-inflammatory compositions
FI49297C (fi) Menetelmä antiserotonisia, anti-histamiinisia ja kipua lieventäviä vai kutuksia omaavien bentso-(b)-bentsofuraano-(2,3-e)-oksepiinijohdannais ten valmistamiseksi.
GB1446829A (en) Pharmaceutical compositions
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
AU458147B2 (en) Processes forthe preparation of dosage units in solid state for medicament
GB911179A (en) Hypnotic and tranquilizing compositions comprising 4, 6-dimethyl-3-pyridazone
YU et al. The studies of the pharmacodynamics of antineoplaston A_ (10)
JPS5721319A (en) Agent for improving desorder of circulatory orgen
Higuchi et al. Studies on the Measuring for the Surface Structure of Clothing (Part 1) On the Measuring Method for Surface Structure of the Body Stand
GB1027760A (en) A therapeutic composition having natriuretic properties and containing an association of flavones
FR2085641A1 (en) Noramidopyrine doxylamine succinate compsn - antiinflammatories analgesics and antipyretics